Paul A Mahon

EVP & GENERAL COUNSEL · United Therapeutics

Paul A Mahon (EVP & GENERAL COUNSEL) filed 24 Form 4 reports in the trailing twelve months (0 purchases, 24 sales), most often in United Therapeutics Corporation (UTHR). The largest single filing was $5.5M of UTHR (10,742 sh across 4 lots, as filed), executed Dec 24 2025. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 24 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$98.2M

shares × price, as filed

Last traded

Nov 5

Filed Nov 5

Median ADV $265.8M across their filed names

Open performance→

Volume by month

Buys $0 Sells $170.0M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 24 filings

Sector per market data · by filing · past 12 months

Most traded names

UTHR

United Therapeutics Corporation UTHR · 0 buys · 42 sells 42 filings

Recent filings

UTHRSALE United Therapeutics Corporation View filing → $5.0M
11,000 sh across 7 lots
Exec Oct 30 2025
Filed Oct 30 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.7M
10,999 sh across 7 lots
Exec Oct 16 2025
Filed Oct 20 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.8M
11,000 sh across 7 lots
Exec Oct 2 2025
Filed Oct 2 2025 · 5:30 PM ET UTHRSALE United Therapeutics Corporation View filing → $4.5M
11,000 sh across 6 lots
Exec Sep 18 2025
Filed Sep 18 2025 · 5:30 PM ET